No Data
No Data
Weigao Group (01066) fell by 18.20%, now at 4.240 yuan, hitting a 52-week low.
As of 11:48, Weigao Group (01066) has dropped by 18.20% compared to the previous closing price, now trading at 4.240 yuan, hitting a 52-week low; the volume is 9.5705 million shares, with a turnover of 40.7507 million Hong Kong dollars.
Buy Recommendation: Undervalued Shandong Weigao Group Poised for Growth Amidst Healthcare Demand Surge
Hong Kong stocks are volatile | Weigao Group (01066) fell more than 8% in the morning, with first-half revenue and profit falling below expectations. UBS Group and CICC both lowered the company's target price.
Weigao Group (01066) fell more than 8% in the morning session. As of the time of writing, it has fallen 6.35% to HKD 4.13, with a turnover of 14.4557 million HKD.
HK$6.74: That's What Analysts Think Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Is Worth After Its Latest Results
Daiwa: Weigao Group rated 'In sync with the overall market', target price lowered to 5.1 Hong Kong dollars
Morgan Stanley released a research report stating that after Weigao Group (01066) announced its interim results, it continued to predict a 4% annual sales growth rate for the company over the next three years, which is slightly conservative compared to the company's sales growth guidance of 5% to 10% in 2024. At the same time, the earnings forecast for 2024 was raised by 1.2%, while the earnings forecast for 2025 and 2026 was reduced by 0.9% and 3% respectively, resulting in a compound annual growth rate of 3% for the three years. Considering the uncertain regulatory backdrop, the weighted average cost of capital assumption was increased from 10.5% to 11%. The target price was lowered from HKD 5.5 to 5.
DBS Keeps Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)
No Data